Medication use among children with autism-spectrum disorders

被引:119
|
作者
Oswald, Donald P. [1 ]
Sonenklar, Neil A. [1 ]
机构
[1] Virginia Commonwealth Univ, Dept Psychiat, Richmond, VA 23298 USA
关键词
D O I
10.1089/cap.2006.17303
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
The study characterizes the use of psychoactive medications among children and youth with autism-spectrum disorders over the course of a calendar year. Eighty-three percent of the sample had at least one drug claim during the year. Prescribed drugs came from 125 different therapeutic classes. The seven most frequently prescribed classes of psychoactive drugs were antidepressants, stimulants, tranquilizers/antipsychotics, anticonvulsants, hypotensive agents, anxiolytic/sedative/hypnotics, and benzodiazepines. The data on other relevant diagnoses indicate that children and youth are frequently treated with medication under an autism-spectrum diagnosis, even though the target symptoms may be commonly associated with other mental disorders. Age data indicate that about 70% of children with autism-spectrum disorders age 8 yr and up receive some form of psychoactive medication in a given year.
引用
收藏
页码:348 / 355
页数:8
相关论文
共 50 条
  • [1] Use of Medication by Young People with Autism-Spectrum Disorders in Quebec
    Sirois, Caroline
    Gascon, Hubert
    Faubert, Mirella
    Gagnon, Marie-Eve
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 : 516 - 516
  • [2] Prevalence and characteristics of children with autism-spectrum disorders
    Nicholas, Joyce S.
    Charles, Jane M.
    Carpenter, Laura A.
    King, Lydia B.
    Jenner, Walter
    Spratt, Eve G.
    ANNALS OF EPIDEMIOLOGY, 2008, 18 (02) : 130 - 136
  • [3] Neuropsychopharmacology of autism-spectrum disorders
    McDougle, CJ
    BIOLOGICAL PSYCHIATRY, 1998, 43 : 4S - 4S
  • [4] Psychotropic medication use among Medicaid-enrolled children with autism spectrum disorders
    Mandell, David S.
    Morales, Knashawn H.
    Marcus, Steven C.
    Stahmer, Aubyn C.
    Doshi, Jalpa
    Polsky, Daniel E.
    PEDIATRICS, 2008, 121 (03) : E441 - E448
  • [5] Use of Psychotropic Medication in Children and Adolescents With Autism Spectrum Disorders
    Coury, Daniel L.
    Anagnostou, Evdokia
    Manning-Courtney, Patricia
    Reynolds, Ann
    Cole, Lynn
    Mccoy, Robin
    Whitaker, Agnes
    Perrin, James M.
    PEDIATRICS, 2012, 130 : S69 - S76
  • [6] Psychotropic Medication Use and Polypharmacy in Children With Autism Spectrum Disorders
    Spencer, Donna
    Marshall, Jaclyn
    Post, Brady
    Kulakodlu, Mahesh
    Newschaffer, Craig
    Dennen, Taylor
    Azocar, Francisca
    Jain, Anjali
    PEDIATRICS, 2013, 132 (05) : 833 - 840
  • [7] Racial and Ethnic Differences in Behavioral Problems and Medication Use Among Children With Autism Spectrum Disorders
    Quebles, Irina
    Solomon, Olga
    Smith, Kathryn A.
    Rao, Sowmya R.
    Lu, Frances
    Azen, Colleen
    Anaya, Grace
    Yin, Larry
    AJIDD-AMERICAN JOURNAL ON INTELLECTUAL AND DEVELOPMENTAL DISABILITIES, 2020, 125 (05): : 369 - 388
  • [8] Use of psychotropic medication among adolescents and adults with autism spectrum disorders
    Fusar-Poli, L.
    Brondino, N.
    Rocchetti, M.
    Petrosino, B.
    Arillotta, D.
    Politi, P.
    Aguglia, E.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S439 - S440
  • [9] An incidence study of diagnosed autism-spectrum disorders among immigrants to the Netherlands
    van der Ven, E.
    Termorshuizen, F.
    Laan, W.
    Breetvelt, E. J.
    van Os, J.
    Selten, J. P.
    ACTA PSYCHIATRICA SCANDINAVICA, 2013, 128 (01) : 54 - 60
  • [10] Innate and adaptive immunity in children with psychotic forms of autism-spectrum disorders
    Kliushnik, T. P.
    Androsova, L. V.
    Simashkova, N. V.
    Zozulya, S. A.
    Otman, I. N.
    Koval-Zaytsev, A. A.
    ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2011, 111 (08) : 41 - 45